Christophe Chevillard Selected Research

Christophe Chevillard Research Topics

Disease

13	Chagas Disease (American Trypanosomiasis) 01/2022 - 12/2013
11	Cardiomyopathies (Cardiomyopathy) 11/2023 - 12/2013
6	Inflammation (Inflammations) 12/2023 - 11/2003
6	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 12/2017
6	Infections 10/2021 - 07/2002
6	Fibrosis (Cirrhosis) 12/2020 - 07/2002
4	Myocarditis (Carditis) 11/2023 - 08/2014
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 01/2016
2	Cardiac Arrhythmias (Arrythmia) 12/2020 - 10/2017
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 12/2013
2	Heart Diseases (Heart Disease) 12/2017 - 01/2015
2	Disease Progression 01/2015 - 10/2009
1	Necrosis 01/2021
1	Hypertrophy 12/2020
1	Myocardial Infarction 01/2016
1	Chagas Cardiomyopathy 05/2015
1	Parasitemia 01/2015
1	Neglected Diseases 01/2014
1	Helminthiasis (Helminthiases) 01/2008
1	Eosinophilia 01/2008
1	Malaria 08/2006
1	alpha-Thalassemia 08/2006
1	Systemic Scleroderma (Systemic Sclerosis) 08/2006
1	Asthma (Bronchial Asthma) 05/2005
1	Schistosomiasis (Bilharziasis) 10/2004
1	Schistosomiasis mansoni 10/2003
1	Liver Diseases (Liver Disease) 07/2002
1	Granuloma 07/2002

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 11/2023 - 07/2002
6	InterferonsIBA 11/2023 - 10/2004
4	MicroRNAs (MicroRNA)IBA 12/2020 - 08/2014
4	Interleukin-13IBA 01/2008 - 10/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 07/2002
3	Interleukin-4 (Interleukin 4)IBA 01/2020 - 05/2005
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2021
2	EnzymesIBA 11/2023 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2017
2	Antiparasitic Agents (Antiparasitics)IBA 08/2014 - 01/2014
2	Interleukin-5 (Interleukin 5)IBA 01/2008 - 05/2005
1	Adenosine Triphosphate (ATP)IBA 11/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Free RadicalsIBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	brequinarIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Sirtuin 1IBA 01/2021
1	Dihydroorotate DehydrogenaseIBA 01/2021
1	AntioxidantsIBA 12/2020
1	NF-kappa B (NF-kB)IBA 12/2017
1	Potassium Channels (Potassium Channel)IBA 10/2017
1	EnkephalinsIBA 10/2017
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	ParaffinIBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Miat long non-coding RNAIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Interleukin-18 (Interleukin 18)IBA 05/2015
1	VaccinesIBA 01/2014
1	ChemokinesIBA 12/2013
1	Connective Tissue Growth FactorIBA 02/2010
1	Interleukin-9 (Interleukin 9)IBA 01/2008
1	Immunoglobulin E (IgE)IBA 01/2008
1	Immunoglobulin G (IgG)IBA 01/2008
1	AllergensIBA 01/2008
1	glucose-6-phosphate dehydrogenase A-IBA 08/2006
1	Sickle HemoglobinIBA 08/2006
1	Blood Group Antigens (Blood Groups)IBA 08/2006
1	AutoantibodiesIBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 10/2004
1	Extracellular Matrix ProteinsIBA 11/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2009